• 1. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

Introduction to 6-Fluoro-4-methoxy-(1H)indazole (CAS No. 885522-57-6)

6-Fluoro-4-methoxy-(1H)indazole, identified by the Chemical Abstracts Service Number (CAS No.) 885522-57-6, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indazole class, a scaffold that is widely recognized for its biological activity and structural versatility. The presence of both a fluoro and a methoxy substituent on the indazole ring introduces unique electronic and steric properties, making it a promising candidate for further exploration in drug discovery.

The structural features of 6-Fluoro-4-methoxy-(1H)indazole contribute to its potential as a pharmacophore in the development of novel therapeutic agents. The fluorine atom, in particular, is known for its ability to enhance metabolic stability and binding affinity, while the methoxy group can influence solubility and bioavailability. These characteristics have made indazole derivatives, including this specific compound, a focus of interest in the design of molecules targeting various biological pathways.

In recent years, there has been a surge in research aimed at identifying new scaffolds for therapeutic intervention. 6-Fluoro-4-methoxy-(1H)indazole has been studied for its potential applications in treating a range of diseases, including cancer, infectious diseases, and inflammatory conditions. The indazole core is particularly noteworthy due to its presence in several already approved drugs, which underscores its biological relevance.

One of the most compelling aspects of 6-Fluoro-4-methoxy-(1H)indazole is its role as a building block in medicinal chemistry. Researchers have leveraged its structure to develop analogs with enhanced pharmacological properties. For instance, modifications to the fluoro and methoxy substituents have led to compounds with improved selectivity and reduced toxicity. These efforts highlight the compound's significance as a starting point for further chemical optimization.

The synthesis of 6-Fluoro-4-methoxy-(1H)indazole involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to achieve high yields and purity, ensuring that the compound is suitable for preclinical and clinical studies. The use of fluorinated intermediates has been particularly crucial in introducing the fluoro group into the indazole core while maintaining structural integrity.

Recent advancements in computational chemistry have also played a pivotal role in understanding the behavior of 6-Fluoro-4-methoxy-(1H)indazole. Molecular modeling studies have provided insights into how this compound interacts with biological targets, such as enzymes and receptors. These insights are invaluable for designing molecules with optimized binding affinities and reduced off-target effects.

In the context of drug discovery, 6-Fluoro-4-methoxy-(1H)indazole has been explored for its potential as an inhibitor or modulator of key enzymes involved in disease pathways. For example, studies suggest that derivatives of this compound may interfere with signaling cascades that are dysregulated in cancer cells. Additionally, its ability to cross the blood-brain barrier has made it an attractive candidate for treating neurological disorders.

The pharmacokinetic properties of 6-Fluoro-4-methoxy-(1H)indazole are also under investigation. Understanding how the body processes this compound is essential for determining appropriate dosing regimens and minimizing side effects. Preliminary studies have indicated that it exhibits favorable pharmacokinetic profiles, which could make it suitable for oral administration.

One notable area of research has been the use of 6-Fluoro-4-methoxy-(1H)indazole in combination therapies. By pairing this compound with other drugs that target different aspects of a disease pathway, researchers aim to achieve synergistic effects that could lead to more effective treatments. This approach aligns with contemporary trends in precision medicine, where personalized treatment plans are tailored to individual patient needs.

The role of 6-Fluoro-4-methoxy-(1H)indazole in addressing emerging infectious diseases has not been overlooked. With the rise of antibiotic-resistant bacteria and other pathogens, there is an urgent need for new therapeutic strategies. Indazole derivatives have shown promise in preliminary screenings for antimicrobial activity, suggesting that further investigation could yield valuable insights into combating infectious diseases.

Environmental considerations have also influenced research into 6-Fluoro-4-methoxy-(1H)indazole. Efforts are being made to develop synthetic routes that minimize waste and reduce environmental impact. Green chemistry principles are being applied to ensure that the production of this compound is sustainable and aligns with global efforts to promote ecological responsibility.

In conclusion, 6-Fluoro-4-methoxy-(1H)indazole (CAS No. 885522-57-6) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and potential biological activities make it a valuable asset in drug discovery efforts aimed at treating various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in developing next-generation therapeutics.

• 1167056-42-9(4-Benzyloxy-6-fluoro 1H-Indazole)
• 1082041-57-3(5-Fluoro-6-methoxy (1H)indazole)
• 3522-07-4(6-Methoxyindazole)
• 478838-63-0(4-fluoro-1H-indazol-5-ol)
• 351210-06-5(4-Methoxy-1H-indazole)
• 887569-13-3(4-Fluoro-6-methoxy-1H-indazole)
• 885521-10-8(6-Fluoro-4-hydroxy (1H)indazole)
• 1000341-74-1(4-fluoro-7-methoxy-1H-indazole)
• 1253791-66-0(4-Fluoro-1H-indazol-6-ol)
• 864500-65-2(1H-INDAZOLE, 6-(2-FLUOROPHENOXY)-)